Live from the NIH registry
Studies recruiting near Chattanooga right now
Top 25 of 137 recruiting studies, sorted by proximity — each links to its official registry page
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Tennessee Oncology, PLLC - Chattanooga Downtown — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Pfizer
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
WR-ClinSearch, LLC — Chattanooga, Tennessee (3.8 mi)
· Sponsor: TriGemX Bio, Inc.
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Chattanooga, Tennessee (3.8 mi)
· Sponsor: AstraZeneca
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Chattanooga Medical Research, Chattanooga — Chattanooga, Tennessee (3.8 mi)
· Sponsor: pH-D Feminine Health LLC
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
T C Thompson Children's Hospital — Chattanooga, Tennessee (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Chattanooga Heart Institute — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Novo Nordisk A/S
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
New Onset Generalized Myasthenia Gravis (gMG)
Phase 4
Interventional 35 participants sought
Erlanger Neuroscience Institute — Chattanooga, Tennessee (3.8 mi)
· Sponsor: argenx
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Chattanooga — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Chronic Total Occlusion of Artery of the Extremities
N/A
Interventional 65 participants sought
Vascular Institute of Chattanooga — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Versono Medical Ltd
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 60 — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Merus B.V.
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Southeast Renal Research Institute — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Boehringer Ingelheim
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
University Diabetes & Endocrine Consultants — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Zucara Therapeutics Inc.
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Myasthenia Gravis, MG
N/A
Observational 70 participants sought
Erlanger Health System — Chattanooga, Tennessee (3.8 mi)
· Sponsor: argenx
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Phase 2
Interventional 130 participants sought
Tennessee Oncology — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Hoffmann-La Roche
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 630 participants sought
Tennessee Oncology Greco Hainsworth Centers For Research Chattanooga — Chattanooga, Tennessee (3.8 mi)
· Sponsor: BeOne Medicines
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Tennessee Oncology, PLLC - Chattanooga Downtown — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Pfizer
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Cervical Cancer
N/A
Interventional 840 participants sought
Chattanooga's Program in Women's Oncology — Chattanooga, Tennessee (3.8 mi)
· Sponsor: GOG Foundation
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Southeast Renal Research Institute — Chattanooga, Tennessee (3.8 mi)
· Sponsor: CSL Behring
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
T C Thompson Children's Hospital — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Children's Oncology Group
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Radiation Retinopathy, Visual Impairment
Phase 3
Interventional 600 participants sought
Southeastern Retina Associates — Hixson, Tennessee (5.2 mi)
· Sponsor: Jaeb Center for Health Research
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Alnylam Pharmaceuticals
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
Phase 2
Interventional 30 participants sought
Ut Erlanger Neurology — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
Community DPC — Cleveland, Tennessee (22.0 mi)
· Sponsor: Cleerly, Inc.
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Non-small Cell Lung Cancer
Phase 3
Interventional 868 participants sought
Greco-Hainsworth Centers for Research ( Site 4034) — Chattanooga, Tennessee (3.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Phase 2
Interventional 987 participants sought
Research Site — Chattanooga, Tennessee (3.8 mi)
· Sponsor: AstraZeneca